Fatma Mama
Psychiatric/Mental Health · Kissimmee, FLNPI 1215687884
Payments from drug & device makers
Across 206 payments — averaging $28.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$2K
- AbbVie$926
- Vanda Pharmaceuticals Inc.$918
- Alkermes, Inc.$782
- Otsuka America Pharmaceutical, Inc.$585
- Indivior Inc.$378
- plus $794 from 6 others
What the payments were for
- Food & beverage$5,90299%
- Education$551%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 61 | $1,573 |
| AbbVie | 25 | $926 |
| Vanda Pharmaceuticals Inc. | 18 | $918 |
| Alkermes, Inc. | 29 | $782 |
| Otsuka America Pharmaceutical, Inc. | 32 | $585 |
| Indivior Inc. | 18 | $378 |
| Teva Pharmaceuticals USA, Inc. | 8 | $299 |
| Luye Pharma (USA) Ltd. | 10 | $174 |
| Axsome Therapeutics, Inc. | 1 | $113 |
| Braeburn Inc. | 1 | $110 |
| E.r. Squibb & Sons, L.L.C. | 2 | $74 |
| Bioxcel Therapeutics, Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$909
- Fanapt$622
- INVEGA SUSTENNA$503
- VRAYLAR$467
- INVEGA TRINZA$129
- ABILIFY ASIMTUFII$125
- ABILIFY MAINTENA$125
- UZEDY$122
- Auvelity$113
- BRIXADI$110
- VIVITROL$100
How this compares
$5,956 in reported general payments places this provider in the 90th percentile of 3,096 psychiatric/mental health providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Divalproex Sodium | 69 | $1,353 |
| Haloperidol | 34 | $998 |
| Quetiapine Fumarate | 54 | $708 |
| Benztropine Mesylate | 45 | $644 |
| Haloperidol Decanoate | 13 | $467 |
| Hydroxyzine Pamoate | 40 | $410 |
| Mirtazapine | 37 | $353 |
| Risperidone | 29 | $342 |
| Perphenazine | 11 | $321 |
| Aripiprazole | 16 | $289 |
| Buspirone Hcl | 19 | $246 |
| Trazodone Hcl | 40 | $242 |
| Lithium Carbonate | 23 | $170 |
| Escitalopram Oxalate | 11 | $61 |
| Fluoxetine Hcl | 14 | $32 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Kissimmee
- Roger RiveraKissimmee$1.6M
- Trinese HardyKissimmee$30K
- Bethanie Simmons BecilJacksonville$782K
- Hannah PhillipsMaitland$455K
- Cheedy JajaTampa$266K
- Scott DurrancePensacola$224K
- Eudaldo AponteHialeah$214K
- Heather WarrenTallahassee$172K
- Angela DavenportAlachua$83K
- Natalie MoodyWinter Haven$75K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.